Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline

https://ift.tt/Kl9DIjw

 

from Sanofi - Aventis Groupe https://ift.tt/ZbBke74
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/sTBw4Re
via IFTTT https://ift.tt/0Mg6b5C